US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

22.50

0.0000

Volume:1.00

Turnover:22.51

Market Cap:2.53B

PE:-11.14

High:22.50

Open:22.50

Low:22.50

Close:22.50

52wk High:29.99

52wk Low:5.45

Shares:112.63M

Float Shares:112.63M

Volume Ratio:0.02

T/O Rate:NaN%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0190

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.newamsterdampharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAMSW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NAMSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","latestPrice":22.5,"timestamp":1770733802601,"preClose":22.5,"halted":0,"volume":1,"delay":0,"changeRate":0,"floatShares":112628458,"shares":112628458,"eps":-2.019,"marketStatus":"Trading","change":0,"latestTime":"02-10 09:54:10 EST","open":22.5,"high":22.5,"low":22.5,"amount":22.51,"amplitude":0,"askPrice":25,"askSize":4379,"bidPrice":21.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.019,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":22.5,"volumeRatio":0.018263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","floatShares":112628458,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.018263,"shares":112628458,"dividePrice":0,"high":22.5,"amplitude":0,"preClose":22.5,"low":22.5,"week52Low":5.45,"pbRate":"--","week52High":29.99,"institutionHeld":0,"latestPrice":22.5,"committee":-0.955347,"eps":-2.019,"divideRate":0,"volume":1,"delay":0,"ttmEps":-2.019,"open":22.5,"prevYearClose":23,"prevWeekClose":20.31,"prevMonthClose":19.45,"prevQuarterClose":23,"fiveDayClose":20,"twentyDayClose":23.95,"sixtyDayClose":28.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMSW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMSW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newamsterdampharma.com","stockEarnings":[{"period":"1week","weight":0.125},{"period":"1month","weight":-0.0605},{"period":"3month","weight":-0.2055},{"period":"6month","weight":0.5901},{"period":"1year","weight":1.2523},{"period":"ytd","weight":-0.0217}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.536633},{"month":2,"riseRate":0.6,"avgChangeRate":0.054027},{"month":3,"riseRate":0.2,"avgChangeRate":-0.24039},{"month":4,"riseRate":0.8,"avgChangeRate":0.178974},{"month":5,"riseRate":0,"avgChangeRate":-0.269123},{"month":6,"riseRate":0.6,"avgChangeRate":-0.001234},{"month":7,"riseRate":0.4,"avgChangeRate":1.643099},{"month":8,"riseRate":0.6,"avgChangeRate":-0.000678},{"month":9,"riseRate":0.4,"avgChangeRate":0.030454},{"month":10,"riseRate":0.8,"avgChangeRate":0.20425},{"month":11,"riseRate":0.8,"avgChangeRate":0.092319},{"month":12,"riseRate":0.6,"avgChangeRate":0.101716}],"exchange":"NASDAQ","name":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","nameEN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":null}}